Updates from the HUGO Gene Nomenclature Committee (HGNC) relevant to Human Genomics readers.
Featured Article: COVID-19 2022 update: transition of the pandemic to the endemic phase
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years. Here, we review the current state of research into the disease with focus on its history, human genetics and genomics and the transition from the pandemic to the endemic phase.
Articles
-
-
Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1
-
Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders
-
Epigenetics may characterize asymptomatic COVID-19 infection
-
A review of deep learning applications in human genomics using next-generation sequencing data
-
The X chromosome and sex-specific effects in infectious disease susceptibility
-
Ernst Wit and John McClure John Wiley & Sons Ltd, Chichester, UK, 2004
-
Human genome meeting 2016
-
Intragraft transcriptional profiling of renal transplant patients with tubular dysfunction reveals mechanisms underlying graft injury and recovery
-
Next-generation sequencing in liquid biopsy: cancer screening and early detection
HGNC updates
From the Blog
Aims and scope
Human Genomics is a peer-reviewed, open access journal that focuses on the application of genomic analysis in all aspects of human health and disease, as well as genomic analysis of drug efficacy and safety, and comparative genomics.
Exposome x Genome
Guest Editors:
Xiaoming Shi, MD/PhD, Director of the National Institute of Environmental Health (NIEH), Chinese Center for Disease Control and Prevention (China CDC)
Nikolaos S. Thomaidis, Professor of Analytical Chemistry, Department of Chemistry, National & Kapodistrian University of Athens
Over the past several decades, genomic analyses (e.g., genome-wide association studies, genome-wide sequencing, functional genomics, epigenomics, and biochemical networks) have enabled unparalleled elucidation of genotype-phenotype associations, which greatly improve our understanding of the pathogenesis of human diseases.
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Previous content
Human Genomics launched with BioMed Central in July 2012, transferring from its previous publisher Henry Stewart Publications. All back content is now available in the archive.
Follow
Annual Journal Metrics
-
Citation Impact
6.481 - 2-year Impact Factor (2021)
5.407 - 5-year Impact Factor (2021)
1.018 - Source Normalized Impact per Paper (SNIP)
1.414 - SCImago Journal Rank (SJR)Speed
39 days to first decision for all manuscripts (Median)
92 days to first decision for reviewed manuscripts only (Median)Usage
461,525 Downloads (2021)
683 Altmetric mentions (2021)